Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04182997 · ClinicalTrials.gov registry record · Phase 4
Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy
A Phase 4 study of Lumbar Disc Herniation, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04182997 is a Phase 4 study of Lumbar Disc Herniation that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 200 participants, above the 88-participant average among 3 other Lumbar Disc Herniation trials with a reported enrollment target (127% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04182997, a Phase 4 study of Lumbar Disc Herniation, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine a grading system for inflammation in lumbar disc herniation and which groups, if any, benefit most from the administration of an intra-operative epidural steroid.
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG saline 0.9%
Study Locations (1)
Missouri
- Missouri Orthopaedic Institute - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-11-21 |
| Est. Completion | 2026-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04182997
The ClinicalTrials.gov registry entry for NCT04182997 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 88-participant average among 3 other Lumbar Disc Herniation trials with a reported enrollment target (127% higher). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lumbar Disc Herniation appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.
NCT04182997 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04182997 about?
NCT04182997 is a clinical study titled "Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy". The purpose of this study is to determine a grading system for inflammation in lumbar disc herniation and which groups, if any, benefit most from the administration of an intra-operative epidural steroid.
What is the current status of trial NCT04182997?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2019-11-21. Estimated completion is 2026-10.
What conditions does trial NCT04182997 study?
This clinical trial studies the following conditions: Lumbar Disc Herniation.
What interventions are being tested in trial NCT04182997?
The interventions under investigation include: Dexamethasone (DRUG), saline 0.9% (DRUG).
Who is sponsoring clinical trial NCT04182997?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04182997 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lumbar Disc Herniation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.